Mangoceuticals, Inc. (NASDAQ:MGRX) Sees Large Growth in Short Interest

Mangoceuticals, Inc. (NASDAQ:MGRX) saw a significant growth in short interest in March. As of March 31st, there was short interest totalling 244,900 shares, a growth of 237.3% from the March 15th total of 72,600 shares. Based on an average daily trading volume, of 157,300 shares, the short-interest ratio is presently 1.6 days. Approximately 7.1% of the shares of the stock are sold short.

Mangoceuticals Trading Up 5.0 %

Shares of NASDAQ:MGRX traded up $0.10 on Wednesday, hitting $2.10. The company had a trading volume of 168,970 shares, compared to its average volume of 242,903. The company has a market cap of $10.85 million, a PE ratio of -0.36 and a beta of 2.41. The business has a 50 day moving average of $3.54 and a 200 day moving average of $6.92. Mangoceuticals has a 52-week low of $1.49 and a 52-week high of $16.80.

Mangoceuticals (NASDAQ:MGRX) last announced its earnings results on Thursday, March 20th. The company reported ($1.01) earnings per share (EPS) for the quarter. The firm had revenue of $0.11 million for the quarter. Mangoceuticals had a negative return on equity of 138.00% and a negative net margin of 1,237.00%.

About Mangoceuticals

Mangoceuticals, Inc develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.